Manufacturing

Review of SUT Adoption in Biopharma Manufacturing

The evolution of therapeutic modalities drives the adoption of single-use technologies.

Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?

Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.

Automating the Future of Fill/Finish

Given the criticality of fill/finish processes, it is clear that automation is the next technological step.

Chime Biologics to Manufacture Novel Antibody Cancer Immunotherapy for Domain Therapeutics

March 14, 2024

In a new manufacturing pact, Chime Biologics will produce DT-7012, Domain Therapeutics' antibody candidate for treating cancer that will soon be entering Phase I studies.

Webcasts

From Lab to Launch: Successful Drug Development Strategies Using Lipid-Based Delivery Systems

March 14, 2024

Webinar Date/Time: Wed, Apr 24, 2024 11:00 AM EDT

Software Advances Mass Customization for Cell and Gene Therapies

March 12, 2024

In an interview, Fabian Gerlinghaus of Cellares outlines a paradigm change in both hardware and software, regulatory expansions, and some positive cost outcomes for the CGT field.

Cellares Set to Launch Good Manufacturing Practice–Compliant Cell Shuttle Manufacturing Platform

March 12, 2024

The Cell Shuttle platform will manufacture cell therapies for its first clinical trials by the end of the year.

Bormioli Pharma’s Business Expands in United States

March 12, 2024

The European company has seen its business increase by 47% in North America.

Alliance for Building Better Medicine Receives NSF Award

March 11, 2024

The Alliance will receive the NSF Regional Innovation Engines Development Award and $1 million in funding.

Jacobs Announces Innovation Hub in Denmark

March 08, 2024

The facility producer’s new innovation hub will offer manufacturing, life sciences, and infrastructure services.

Cellares Innovates With Automated Cell and Gene Therapy Platform

March 07, 2024

Cellares CEO Fabian Gerlinghaus shares how an automated, closed-production platform with a small footprint can dramatically impact cost savings and scalability for cell and gene therapies.

Webcasts

Microdosing: A Powder-in-Capsule Technology Pathway from Development to Commercialization

March 07, 2024

Webinar Date/Time: Tue, Mar 26, 2024 11:00 AM EDT

Webcasts

Transferring Energy to Hot Melt Extrusions

March 06, 2024

Webinar Date/Time: Friday, April 5, 2024 at 11amEDT | 10am CDT | 8am PDT